UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 73

Sortiert nach

Cost Analysis of Flexible Ureteroscope Repairs: Evaluation of 655 Procedures in a Community-Based Practice

Journal of endourology, 2016-03, Vol.30 (3), p.254

2016

Volltextzugriff (PDF)

Quality of Life in the Phase 2/3 Trial of N-803 Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin‒Unresponsive Nonmuscle-Invasive Bladder Cancer

Urology practice, 2024-03, Vol.11 (2), p.367

2024

Volltextzugriff (PDF)

Aquablation therapy in large prostates (80–150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3‐year trial results

BJUI compass, 2022-03, Vol.3 (2), p.130-138

2022

Volltextzugriff (PDF)

Clinical variables and stone detection in patients with flank pain

Canadian journal of urology, 2016-10, Vol.23 (5), p.8441

2016

Volltextzugriff (PDF)

WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation® vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia

The Journal of urology, 2018-05, Vol.199 (5), p.1252-1261

2018

Volltextzugriff (PDF)

Providing Access to Care through a 24-Hour Dedicated Stone Line

Urology practice, 2017-01, Vol.4 (1), p.43-47

2017

Volltextzugriff (PDF)

Clinical and economic impact of implementation of slow shockwave lithotripsy for the treatment of urinary calculi

Journal of endourology, 2010-09, Vol.24 (9), p.1483

2010

Volltextzugriff (PDF)

PLLBA-01 FINAL CLINICAL RESULTS OF PIVOTAL TRIAL OF IL-15RΑFC SUPERAGONIST N-803 WITH BCG IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) CIS AND PAPILLARY COHORTS

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Volltextzugriff (PDF)

Randomized Controlled Trial of Aquablation versus Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia: One-year Outcomes

Urology (Ridgewood, N.J.), 2019-03, Vol.125, p.169-173

2019

Volltextzugriff (PDF)

Quality of life in QUILT 3.032 study: Patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) receiving IL-15RαFc superagonist N-803 plus BCG

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.495-495

2023

Volltextzugriff (PDF)

Final clinical results of pivotal trial of IL-15RαFc superagonist N-803 with BCG in BCG-unresponsive CIS and papillary nonmuscle-invasive bladder cancer (NMIBC)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4508-4508

2022

Volltextzugriff (PDF)

Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial Results

The Journal of urology, 2023-07, Vol.210 (1), p.143-153

2023

Volltextzugriff (PDF)

Positive efficacy and safety phase 3 results in both CIS and papillary cohorts BCG-unresponsive nonmuscle invasive bladder cancer (NMIBC) after IL-15RαFc superagonist N-803 (Anktiva) and BCG infusion

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.431-431

2022

Volltextzugriff (PDF)

WATER II (80–150 mL) procedural outcomes

BJU international, 2019-01, Vol.123 (1), p.106-112

2019

Volltextzugriff (PDF)

Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year Results

Urology (Ridgewood, N.J.), 2019-07, Vol.129, p.1-7

2019

Volltextzugriff (PDF)

Phase II/III clinical results of IL-15RαFc superagonist N-803 with BCG in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) carcinoma in situ (CIS) patients

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.510-510

2021

Volltextzugriff (PDF)

MP37-20 POST VASECTOMY SEMEN ANALYSIS: DOES PATIENT CONVENIENCE IMPROVE COMPLIANCE?

The Journal of urology, 2016-04, Vol.195 (4), p.e504-e504

2016

Volltextzugriff (PDF)

Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trial

BJU international, 2019-04, Vol.123 (4), p.651-660

2019

Volltextzugriff (PDF)

Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trial

Canadian journal of urology, 2020-02, Vol.27 (1), p.10072

2020

Volltextzugriff (PDF)

MP63-01 AN INTERIM ANALYSIS OF A PHASE II CLINICAL STUDY OF INTRAVESICAL PHOTO DYNAMIC THERAPY IN PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) CARCINOMA IN-SITU (CIS)

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Volltextzugriff (PDF)

A phase II clinical study of intravesical photo dynamic therapy in patients with BCG-unresponsive NMIBC (interim analysis)

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.528-528

2023

Volltextzugriff (PDF)

Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH

Canadian journal of urology, 2022-02, Vol.29 (1), p.10960

2022

Volltextzugriff (PDF)

MP28-06 COST ANALYSIS OF FLEXIBILE URETEROSOPE REPAIRS: EVALUATION OF 655 PROCEDURES IN A COMMUNITY-BASED PRACTICE EXPERIENCE

The Journal of urology, 2015-04, Vol.193 (4), p.e313-e313

2015

Volltextzugriff (PDF)

Two-Year Outcomes After Aquablation Compared to TURP: Efficacy and Ejaculatory Improvements Sustained

Advances in therapy, 2019-06, Vol.36 (6), p.1326-1336

2019

Volltextzugriff (PDF)

PD56-05 THREE-YEAR OUTCOMES AFTER AQUABLATION COMPARED TO TURP: EFFICACY AND EJACULATORY IMPROVEMENTS SUSTAINED

The Journal of urology, 2020-04, Vol.203 (Supplement 4)

2020

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(73)

Sprache

Englisch
(73)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(44)
Life Sciences & Biomedicine
(41)
Science & Technology
(41)
Male
(36)
Urology & Nephrology
(34)
Biological And Medical Sciences
(25)
Medical Sciences
(25)
Middle Aged
(25)
Aged
(24)
Female
(14)
Nephrology. Urinary Tract Diseases
(13)
Urology
(13)
Time Factors
(10)
Adult
(9)
Follow-Up Studies
(9)
Ablation Techniques - Methods
(8)
Prostate Cancer
(8)
Prostatic Hyperplasia - Surgery
(8)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(8)
Treatment Outcome
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cost Analysis of Flexible Ureteroscope Repairs: Evaluation of 655 Procedures in a Community-Based Practice

Quality of Life in the Phase 2/3 Trial of N-803 Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin‒Unresponsive Nonmuscle-Invasive Bladder Cancer

Aquablation therapy in large prostates (80–150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3‐year trial results

Clinical variables and stone detection in patients with flank pain

WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation® vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia

Providing Access to Care through a 24-Hour Dedicated Stone Line

Clinical and economic impact of implementation of slow shockwave lithotripsy for the treatment of urinary calculi

PLLBA-01 FINAL CLINICAL RESULTS OF PIVOTAL TRIAL OF IL-15RΑFC SUPERAGONIST N-803 WITH BCG IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) CIS AND PAPILLARY COHORTS

Randomized Controlled Trial of Aquablation versus Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia: One-year Outcomes

Quality of life in QUILT 3.032 study: Patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) receiving IL-15RαFc superagonist N-803 plus BCG

Final clinical results of pivotal trial of IL-15RαFc superagonist N-803 with BCG in BCG-unresponsive CIS and papillary nonmuscle-invasive bladder cancer (NMIBC)

Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial Results

Positive efficacy and safety phase 3 results in both CIS and papillary cohorts BCG-unresponsive nonmuscle invasive bladder cancer (NMIBC) after IL-15RαFc superagonist N-803 (Anktiva) and BCG infusion

WATER II (80–150 mL) procedural outcomes

Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year Results

Phase II/III clinical results of IL-15RαFc superagonist N-803 with BCG in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) carcinoma in situ (CIS) patients

MP37-20 POST VASECTOMY SEMEN ANALYSIS: DOES PATIENT CONVENIENCE IMPROVE COMPLIANCE?

Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trial

Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trial

MP63-01 AN INTERIM ANALYSIS OF A PHASE II CLINICAL STUDY OF INTRAVESICAL PHOTO DYNAMIC THERAPY IN PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) CARCINOMA IN-SITU (CIS)

A phase II clinical study of intravesical photo dynamic therapy in patients with BCG-unresponsive NMIBC (interim analysis)

Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH

MP28-06 COST ANALYSIS OF FLEXIBILE URETEROSOPE REPAIRS: EVALUATION OF 655 PROCEDURES IN A COMMUNITY-BASED PRACTICE EXPERIENCE

Two-Year Outcomes After Aquablation Compared to TURP: Efficacy and Ejaculatory Improvements Sustained

PD56-05 THREE-YEAR OUTCOMES AFTER AQUABLATION COMPARED TO TURP: EFFICACY AND EJACULATORY IMPROVEMENTS SUSTAINED

Suchergebnisse filtern